本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Genmab A/S

25.58
-0.2700-1.04%
成交量:89.66萬
成交額:2,287.37萬
市值:164.32億
市盈率:16.64
高:25.78
開:25.47
低:25.34
收:25.85
52周最高:35.43
52周最低:17.24
股本:6.42億
流通股本:6.35億
量比:0.90
換手率:0.14%
股息:- -
股息率:- -
每股收益(TTM):1.54
每股收益(LYR):1.54
淨資產收益率:17.53%
總資產收益率:8.10%
市淨率:2.81
市盈率(LYR):16.64

資料載入中...

公司資料

公司名字:
Genmab A/S
交易所:
NASDAQ
成立時間:
1998
員工人數:
2973
公司地址:
Carl Jacobsens Vej 30,Valby,Copenhagen,Capital Region of Denmark,Denmark
郵編:
2500
傳真:
- -
簡介:
Genmab A/S於1998年6月11日註冊成立。該公司是一家國際生物技術公司,擁有一系列基於抗體的新型產品和候選產品,旨在滿足癌症和其他嚴重疾病患者的醫療需求,並改善其治療結果。公司建立其產品線的目標是在他們認為能夠最大化其價值並對治療領域產生有意義影響的地理區域,將藥物推向市場。

董事

名稱
職位
Deirdre P. Connelly
Chair of the Board and Independent Director
Elizabeth O'Farrell
Independent Director
Paolo Paoletti
Independent Director
Pernille Erenbjerg
Deputy Chair and Independent Director
Rolf Hoffmann
Independent Director
Anders Gersel Pedersen
Director
Martin Schultz
Director
Michael Kavanagh
Director
Mijke Zachariasse
Director

股東

名稱
職位
Jan G. J. van de Winkel
Chief Executive Officer and President
Anthony Pagano
Executive Vice President and Chief Financial Officer
Brad Bailey
Chief Commercial Officer and Executive Vice President
Christopher Cozic
Chief People Officer and Executive Vice President
Greg Mueller
Executive Vice President,General Counsel & Chief Legal Officer
Judith Klimovsky
Chief Development Officer and Executive Vice President
Martine J. van Vugt
Chief Strategy Officer and Executive Vice President
Rayne Waller
Chief Technical Operations Officer and Executive Vice President
Tahamtan Ahmadi
Executive Vice President and Chief Medical Officer, Head of Experimental Medicines